Full List Of Stories
Growth in US oil stockpiles slowed last week, DoE says
Oil stockpiles in the US rose during the preceding week despite a sharp fall in domestic output, linked to tropical storm Cristobal, and a reduction in net imports.
Europe close: Stocks trim gains with Beijing Covid-19 outbreak in focus
Stocks finished modestly higher on Wednesday with some analysts crediting central bank support, even as investors kept a close eye on an outbreak of Covid-19 in Beijing and mounting numbers of new infections in the States.
Biden widens lead over Trump in latest Reuters/Ipsos poll
Presumptive Democratic party presidential hopeful, Joe Biden, widened his lead over rival Donald Trump to 13 points, his biggest advantage thus far in 2020, according to a poll published on Wednesday.
Thursday preview: BoE, central banks in focus
The focus on Thursday will be firmly on the Bank of England's policy decision.
Taylor Wimpey to raise funds via accelerated bookbuild
Taylor Wimpey will sell new shares in order to be able to take full advantage of "significant near-term opportunities" in the land market.
Canaccord raises target on Premier Oil but sees shares 'fully valued'
Analysts at Canaccord Genuity raised their target price for shares of Premier Oil, but kept their recommendation at a 'hold', arguing that they were fully valued.
US housing starts fall short of forecasts in May
Homebuilders in the US broke ground on fewer new homes than expected last month, but some economists were sanguine.
'Frugal Four' call for EU reconstruction fund to be based on loans
Leaders in Austria, Denmark, Holland and Sweden have called for all spending tied to a proposed economic reconstruction fund for the European Union to be 'responsible' and financed via debt, instead of grants.
Curevac Covid-19 vaccine could get regulatory thumbs-up by mid-2021
German biotechnology outfit CureVac has clinched approval to begin human trials of its Covid-19 vaccine candidate, although even in the best of cases a request for regulatory approval is not expected until early 2021.
Europe midday: Stocks up despite risks of second Covid-19 wave
Stocks are posting moderate gains on Wednesday thanks, said some analysts, to central bank support, even as investors kept a close eye on an outbreak of Covid-19 in Beijing and mounting numbers of new infections in the States.